This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Bioventures, LLC. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Sajid Khan - Innovator in Cancer Treatment
Introduction
Sajid Khan is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic compounds.
Latest Patents
Sajid Khan holds 1 patent for his work on BCL-2 proteins degraders for cancer treatment. This patent presents compositions and methods for selectively killing cancer cells, utilizing a compound of Formula (I). The invention demonstrates improved potency and safety profiles compared to similar compounds, particularly showing reduced platelet toxicity while retaining or improving toxicity in cancer cells.
Career Highlights
Sajid Khan is associated with Bioventures, LLC, where he continues to advance his research in oncology. His work focuses on developing innovative solutions that can significantly impact cancer therapies.
Collaborations
Some of his notable coworkers include Guangrong Zheng and Daohong Zhou, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Sajid Khan's contributions to cancer treatment through his innovative patents highlight the importance of research in developing effective therapies. His work exemplifies the potential of targeted treatments in improving patient outcomes.